Overview

Growth Retardation In Children With Special Pathological Conditions Or Disease

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
To show an increase in annual growth rate 3 years after Visit 2. Annual growth rate in standard deviation (SD) after 3 years will be compared to growth rate before the start of GH treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer